Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP]. | Zhongguo Zhong Yao Za Zhi | 2023 | 37802875 | PubTator, text mining | PubMed |
| Erdr1 orchestrates macrophage polarization and determines cell fate via dynamic interplay with YAP1 and Mid1. | bioRxiv | 2023 | 37781614 | PubTator, text mining | PubMed |
| Editorial: Molecular markers in rheumatic diseases and their comorbidities. | Front Med (Lausanne) | 2023 | 37771984 | PubTator, text mining | PubMed |
| Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings. | Bioorg Med Chem Lett | 2023 | 37770003 | PubTator, text mining | PubMed |
| Matricellular Proteins in the Homeostasis, Regeneration, and Aging of Skin. | Int J Mol Sci | 2023 | 37762584 | PubTator, text mining | PubMed |
| EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression. | Cancers (Basel) | 2023 | 37760488 | PubTator, text mining | PubMed |
| AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation. | Antioxidants (Basel) | 2023 | 37759984 | PubTator, text mining | PubMed |
| The Current State of Research on Sirtuin-Mediated Autophagy in Cardiovascular Diseases. | J Cardiovasc Dev Dis | 2023 | 37754811 | PubTator, text mining | PubMed |
| Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma. | Medicine (Baltimore) | 2023 | 37746966 | PubTator, text mining | PubMed |
| Single-Cell RNA sequencing investigation of female-male differences under PAD conditions. | Front Cardiovasc Med | 2023 | 37745110 | PubTator, text mining | PubMed |
| YAP1 affects the prognosis through the regulation of stemness in endometrial cancer. | PeerJ | 2023 | 37744228 | PubTator, text mining | PubMed |
| YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis. | Nat Commun | 2023 | 37739954 | PubTator, text mining | PubMed |
| The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation. | Nucleic Acids Res | 2023 | 37739411 | PubTator, text mining | PubMed |
| Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology. | J Cancer Res Clin Oncol | 2023 | 37733241 | PubTator, text mining | PubMed |
| Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency. | Mol Cancer | 2023 | 37730636 | PubTator, text mining | PubMed |
| The landscape of implantation and placentation: deciphering the function of dynamic RNA methylation at the maternal-fetal interface. | Front Endocrinol (Lausanne) | 2023 | 37720526 | PubTator, text mining | PubMed |
| HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. | Cell Death Dis | 2023 | 37709768 | PubTator, text mining | PubMed |
| Expression and function of CCN2-derived circRNAs in chondrocytes. | J Cell Commun Signal | 2023 | 37695440 | PubTator, text mining | PubMed |
| Osteopathic Approach for Keloids and Hypertrophic Scars. | Cureus | 2023 | 37692181 | PubTator, text mining | PubMed |
| Sildenafil, a phosphodiesterase-5 inhibitor, stimulates angiogenesis and bone regeneration in an atrophic non-union model in mice. | J Transl Med | 2023 | 37684656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=18